News Category
Viromed Medical AG signs distribution agreements for its cold plasma device ViroCAP® in Spain, Portugal, Greece, the Balkans, Romania, and Saudi Arabi...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant step toward a potential neuroprotective therapy for mult...
PX1 Research introduces US-manufactured sublingual peptide strips for needle-free research, offering verified purity and cGMP compliance.
PX1 Research's adoption of seven-stage HPLC purity testing and cGMP standards in US-based manufacturing ensures batch-specific documentation, addressi...
NanoViricides has received approval to start a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a more accessibl...
Research from the University of Virginia suggests focused ultrasound can enhance drug delivery to gliomas, potentially improving brain cancer treatmen...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in triple-negative breast cancer models, s...
Park-Ohio's second quarter results indicate a positive inflection, with improved margins and raised guidance, signaling stronger core portfolio perfor...
The opening of two flagship campuses marks a significant expansion for ICON Smile Studios, integrating multiple dental specialties under one roof to e...
Scinai Immunotherapeutics has appointed Eran Kuratz to head supply chain and business process administration for its CDMO subsidiary, a move that stre...
Quantum BioPharma's FDA clearance for Lucid-MS to enter Phase 2 trials marks a pivotal step in developing a neuroprotective therapy for multiple scler...
Tonix Pharmaceuticals' second-quarter 2026 revenue surged to $13.5 million, primarily due to impressive TONMYA sales, signaling robust market adoption...
Tonix Pharmaceuticals' second-quarter revenue jumped to $13.5 million driven by TONMYA's strong launch, positioning the company for sustained growth i...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, driven by TONMYA sales, demonstrating commercial viability and supporting pipeline pro...
Voyageur Pharmaceuticals advances its Mueller iodine extraction process with 99.8% purity and over 90% recovery in lab tests, moving toward field pilo...
OffScript's new nootropic mints offer fully disclosed dosing and third-party testing, addressing consumer demand for transparency in the supplement in...
A new narrative review provides a comprehensive framework for risk-adapted neuroblastoma care, emphasizing molecular and clinical factors to tailor tr...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration implant through clinical trials, FDA submission preparation, and European comm...
Quantum BioPharma advances a two-pronged approach to neurological health, combining its investigational MS therapy Lucid-MS with its supplement unbuzz...
Quantum BioPharma is advancing a two-pronged approach to neurological health, targeting myelin repair in multiple sclerosis with Lucid-MS and addressi...
VERAXA Biotech's proprietary BiTAC platform and pipeline of next-generation antibody therapeutics position it for potential partnerships and licensing...
A Spanish patient initially treated for brain cancer was found to have pork tapeworm cysts, underscoring the importance of proper pork preparation and...
Veetee USA appoints CPG veteran Kevin Stitt to lead retail expansion at Walmart and Publix, leveraging its unique steam cooking process and upcoming S...
Lantern Pharma's upcoming webcast signals continued momentum in its AI-driven oncology pipeline and commercial AI platform, underscoring its strategic...
Earth Science Tech's fiscal Q1 2027 results show a 57% net income surge, signaling strong operational performance and strategic growth.
Thorium Atomics has initiated pre-application engagement with the U.S. Nuclear Regulatory Commission for its Tesseract TGR advanced reactor, marking a...
VERAXA Biotech has advanced its VXA-222 bispecific ADC program past the discovery phase and expanded its patent portfolio, underscoring its progress i...
American Fusion Inc. files six new patent applications, reaching 82 total, and progresses toward OTCQB listing and next-phase testing, underscoring it...
Nano-X Imaging's $8 million registered direct offering underscores its commitment to advancing affordable medical imaging and preventive healthcare, w...
A novel liquid biopsy offers a simpler method to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving trea...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA mpox/smallpox vaccine, positioning it f...
Innovative Designs, Inc. announces record fiscal third-quarter revenues, marking its eighth straight profitable quarter, and advances its Insultex Hou...
The July Wellness Index Report highlights a growing trend in longevity medicine that prioritizes supporting the body's natural processes over overridi...
Regentis Biomaterials' European approval of a next-generation manufacturing process for GelrinC enhances production yield by 400%, reducing costs and ...
Purple Exhibits announces comprehensive turnkey services for KBIS 2027, led by Key Account Manager Joey Bartman, ensuring exhibitors benefit from spec...
Onco-Innovations is combining PNKP-targeted DDR inhibition, nanoparticle delivery, and causal AI to accelerate cancer drug development, with lead cand...
Earth Science Tech's strategic focus on vertical integration and proprietary technology in telehealth and peptide therapy underscores its potential to...
Episode 812 of DH Unplugged analyzes the volatile market reactions to Big Tech earnings, the KOSPI crash, and SpaceX's post-IPO decline, highlighting ...
Nagoya University researchers discovered that the immune protein C3, when produced within tumors, can make them more susceptible to immunotherapy, pot...
American Fusion's CTO presented the Texatron Fusion Engine program and GEM Unification Theory at the APS DPF 2026 Meeting, boosting the company's visi...
VolitionRx's new Capture-Seq technology achieves >99% pure ctDNA isolation, potentially transforming cancer detection and monitoring, with a combined ...
Tonix Pharmaceuticals announced its participation in two key investor conferences, highlighting its ongoing efforts to engage with the investment comm...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, strength...
LataMed AI Corp. will present at a university conference in Venezuela, highlighting the role of AI in healthcare and systems engineering, which unders...
NeuroThera Labs has initiated its Phase IIb clinical trial at Yale Child Study Center, advancing a potential new cannabinoid-based treatment for Toure...
Medios AG has appointed Katrin Neuffer as Director Investor Relations & Communications, bringing her extensive capital markets experience to guide the...
SRX Global's investment in Vistagen Therapeutics underscores its strategy to unlock value in undervalued biopharmaceutical assets, potentially influen...
SRX Global's acquisition of a stake in Vistagen highlights its strategy of investing in undervalued high-conviction companies and engaging with manage...
